• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

塞来昔布晶体习性的改性以改善可加工性。

Modification of the crystal habit of celecoxib for improved processability.

作者信息

Banga Sheere, Chawla Garima, Varandani Deepak, Mehta B R, Bansal Arvind K

机构信息

Department of Pharmaceutical Technology (Formulations), National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, S.A.S. Nagar, Punjab - 160 062, India.

出版信息

J Pharm Pharmacol. 2007 Jan;59(1):29-39. doi: 10.1211/jpp.59.1.0005.

DOI:10.1211/jpp.59.1.0005
PMID:17227618
Abstract

Crystallization is often used in the pharmaceutical industry for purification and isolation of drugs, and also as a means of generating polymorphs or isomorphs. The aim of this study was to investigate the role of extrinsic crystallization parameters on the crystallized product, with special emphasis on improving the mechanical properties of acicular celecoxib. Celecoxib isomorphs were prepared using different techniques (solvent crystallization and vapour diffusion) and crystallization conditions (solvents, stirring, degree of supersaturation, crystallization temperature and seeding). Powder X-ray diffractometry, spectroscopic and thermal methods were used to investigate physical characteristics of crystals. Growth kinetics and aggregation dynamics of crystallization in polar and non-polar solvents were simulated using a dynamic light scattering method. The quick appearance of broad peaks over the range of 10-8000 nm in chloroform during crystallization simulation studies indicated faster aggregation in non-polar solvents. Aspect ratio, flow, compressibility and surface area of recrystallized products were also determined. Surface topography was determined by atomic force microscopy and the lath-shaped crystals (aspect ratio of 2-4) exhibited a roughness index of 1.79 in comparison with 2.92 for needles. Overall, the lath-shaped isomorphs exhibited improved flow and better compressibility.

摘要

结晶在制药工业中常用于药物的纯化和分离,也是生成多晶型物或同晶型物的一种手段。本研究的目的是研究外在结晶参数对结晶产物的作用,特别着重于改善针状塞来昔布的机械性能。采用不同技术(溶剂结晶和气相扩散)和结晶条件(溶剂、搅拌、过饱和度、结晶温度和晶种)制备了塞来昔布同晶型物。使用粉末X射线衍射法、光谱法和热分析法研究晶体的物理特性。采用动态光散射法模拟了极性和非极性溶剂中结晶的生长动力学和聚集动力学。在结晶模拟研究中,氯仿中10 - 8000 nm范围内宽峰的快速出现表明非极性溶剂中聚集更快。还测定了重结晶产物的长径比、流动性、可压缩性和表面积。通过原子力显微镜测定表面形貌,板条状晶体(长径比为2 - 4)的粗糙度指数为1.79,而针状晶体为第二点九二。总体而言,板条状同晶型物表现出改善的流动性和更好的可压缩性。

相似文献

1
Modification of the crystal habit of celecoxib for improved processability.塞来昔布晶体习性的改性以改善可加工性。
J Pharm Pharmacol. 2007 Jan;59(1):29-39. doi: 10.1211/jpp.59.1.0005.
2
Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.使用煅烧的镁铝水滑石提高塞来昔布无定形形式的稳定性。
Eur J Pharm Biopharm. 2007 May;66(2):253-9. doi: 10.1016/j.ejpb.2006.10.006. Epub 2006 Oct 17.
3
Crystal modification of dipyridamole using different solvents and crystallization conditions.使用不同溶剂和结晶条件对双嘧达莫进行晶型修饰。
Int J Pharm. 2006 Sep 14;321(1-2):27-34. doi: 10.1016/j.ijpharm.2006.04.021. Epub 2006 May 13.
4
Preparation and physicochemical and preclinical evaluations of recrystallized celecoxib.
PDA J Pharm Sci Technol. 2007 Sep-Oct;61(5):362-74.
5
Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.含储存和压缩稳定剂的无定形塞来昔布喷雾干燥共沉淀物的研制
Acta Pharm. 2007 Sep;57(3):287-300. doi: 10.2478/v10007-007-0023-7.
6
Solid-state properties and crystallization behavior of PHA-739521 polymorphs.PHA - 739521多晶型物的固态性质及结晶行为
Int J Pharm. 2006 Aug 17;319(1-2):114-20. doi: 10.1016/j.ijpharm.2006.03.044. Epub 2006 Apr 7.
7
Solid dispersion of spironolactone with porous silica prepared by the solvent method.通过溶剂法制备的螺内酯与多孔二氧化硅的固体分散体。
Pharmazie. 2007 Aug;62(8):599-603.
8
Impact of differential surface molecular environment on the interparticulate bonding strength of celecoxib crystal habits.不同表面分子环境对塞来昔布晶体习性间的颗粒结合强度的影响。
Int J Pharm. 2014 Jan 2;460(1-2):189-95. doi: 10.1016/j.ijpharm.2013.10.029. Epub 2013 Oct 20.
9
Design and evaluation of celecoxib porous particles using melt sonocrystallization.使用熔体声结晶法设计和评估塞来昔布多孔颗粒
Pharm Res. 2006 Jun;23(6):1395-400. doi: 10.1007/s11095-006-0020-4. Epub 2006 Jun 7.
10
Design and characterization of microcrystals for enhanced dissolution rate of celecoxib.用于提高塞来昔布溶解速率的微晶的设计与表征
Curr Drug Discov Technol. 2013 Dec;10(4):305-14. doi: 10.2174/15701638113109990035.

引用本文的文献

1
Carrier-Free Inhalable Dry Microparticles of Celecoxib: Use of the Electrospraying Technique.塞来昔布无载体可吸入干燥微粒:电喷雾技术的应用。
Biomedicines. 2023 Jun 17;11(6):1747. doi: 10.3390/biomedicines11061747.
2
Impact of Crystal Habit on the Dissolution Rate and In Vivo Pharmacokinetics of Sorafenib Tosylate.托法替尼对索拉非尼晶体形态的影响及其在体内的药代动力学。
Molecules. 2021 Jun 7;26(11):3469. doi: 10.3390/molecules26113469.